Immatics NV (IMTX)
10.74
-0.03
(-0.28%)
USD |
NASDAQ |
May 06, 16:00
10.72
-0.02
(-0.14%)
Pre-Market: 20:00
Immatics Profit Margin (Quarterly): -164.2% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -164.2% |
| September 30, 2023 | -447.0% |
| June 30, 2023 | -110.1% |
| March 31, 2023 | -201.6% |
| December 31, 2022 | -35.15% |
| September 30, 2022 | -139.0% |
| June 30, 2022 | -81.21% |
| March 31, 2022 | 83.24% |
| December 31, 2021 | -106.7% |
| September 30, 2021 | -422.2% |
| Date | Value |
|---|---|
| June 30, 2021 | -511.4% |
| March 31, 2021 | -308.2% |
| December 31, 2020 | -190.2% |
| September 30, 2020 | -2.08K% |
| June 30, 2020 | -305.1% |
| March 31, 2020 | -118.0% |
| December 31, 2019 | -335.6% |
| September 30, 2019 | -93.18% |
| June 30, 2019 | -120.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.08K%
Minimum
Sep 2020
83.24%
Maximum
Mar 2022
-299.4%
Average
-164.2%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| MorphoSys AG | 81.70% |
| Affimed NV | -4.89K% |
| InflaRx NV | -696.8K% |
| BioNTech SE | 30.96% |
| CureVac NV | -384.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -43.95% |
| Return on Assets | -22.61% |
| Return on Invested Capital | -43.95% |
| Operating Margin (Quarterly) | -174.1% |
| Return on Net Operating Assets | -175.5% |